Organogenesis Holdings Inc. (FRA:2PQ)
3.340
+0.020 (0.60%)
At close: Jan 30, 2026
Organogenesis Holdings Revenue
Organogenesis Holdings had revenue of $150.86M USD in the quarter ending September 30, 2025, with 30.98% growth. This brings the company's revenue in the last twelve months to $465.22M, up 2.24% year-over-year. In the year 2024, Organogenesis Holdings had annual revenue of $482.04M with 11.29% growth.
Revenue (ttm)
$465.22M
Revenue Growth
+2.24%
P/S Ratio
1.08
Revenue / Employee
$535.35K
Employees
869
Market Cap
427.29M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 482.04M | 48.90M | 11.29% |
| Dec 31, 2023 | 433.14M | -17.75M | -3.94% |
| Dec 31, 2022 | 450.89M | -16.47M | -3.52% |
| Dec 31, 2021 | 467.36M | 129.06M | 38.15% |
| Dec 31, 2020 | 338.30M | 77.32M | 29.63% |
| Dec 31, 2019 | 260.98M | 67.53M | 34.91% |
| Dec 31, 2018 | 193.45M | -5.06M | -2.55% |
| Dec 31, 2017 | 198.51M | 59.78M | 43.09% |
| Dec 31, 2016 | 138.73M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| FRoSTA Aktiengesellschaft | 652.00M |
| SIMONA Aktiengesellschaft | 586.42M |
| Südwestdeutsche Salzwerke AG | 347.96M |
| EUROKAI GmbH & Co. KGaA | 262.47M |
| Novabase S.G.P.S. | 130.35M |
| Wild Bunch AG | 68.86M |
| EUWAX Aktiengesellschaft | 41.42M |
| STINAG Stuttgart Invest AG | 28.92M |
Organogenesis Holdings News
- 10 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO - PRNewsWire
- 11 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO - GlobeNewsWire
- 5 weeks ago - Organogenesis, MiMedx among decliners as Medicare to pull skin substitute LCDs - Seeking Alpha
- 5 weeks ago - Organogenesis Initiates BLA Submission For ReNu In Knee Arthritis - Nasdaq
- 5 weeks ago - Organogenesis (ORGO) Advances ReNu BLA Submission for Knee Arthritis - GuruFocus
- 5 weeks ago - Organogenesis starts rolling submission for ReNu allograft for knee arthritis - Seeking Alpha
- 5 weeks ago - Organogenesis (ORGO) Begins Rolling Submission for FDA Approval of ReNu - GuruFocus
- 5 weeks ago - Organogenesis Announces Initiation of Biologics License Application for ReNu - Wallstreet:Online